Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel process for genetic engineering preparation of insulin and insulin analogs

A technology for insulin and insulin precursors, applied in the field of bioengineering, which can solve the problems of complex preparation methods of final products, mismatched disulfide bonds, and low expression of gene recombination methods

Inactive Publication Date: 2005-11-23
费俭
View PDF8 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The chemical synthesis method is costly, while the genetic recombination method has disadvantages such as low expression, disulfide bond mismatch, and complicated preparation of the final product.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel process for genetic engineering preparation of insulin and insulin analogs
  • Novel process for genetic engineering preparation of insulin and insulin analogs
  • Novel process for genetic engineering preparation of insulin and insulin analogs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] Construction of expression vector

[0078] The codon usage of P. pastoris is basically similar to that of S. cerevisiae, but there are some differences in individual amino acids such as Glu [Zhao, X., Huo, K.K. and Li, Y.Y.(2000). Synonymous codon usage in Pichia pastoris Sheng Wu Gong Cheng XueBao16(3):308-11.]. Chemical synthesis of monomeric insulin B following the codon preference of P. pastoris 27 K-DTrI precursor gene fragment (Fig. 1A).

[0079] Chemically synthesize code B by the same method 1 A B 27 K-DTrI (Fig. 1B) and (DesB 1 )B 27 DNA of K-DTrI (Fig. 1C). Similar to S.cerevisiae, a suitable prepro-leader is helpful for the secretion and expression of insulin precursors in P.pastoris, and the chemically synthesized DNA fragments are cloned into the EcoRI and NotI sites of the pPIC9K plasmid (Invitrogen Company) to form α- Mating factor leader-EAEAYVEFK-MIP expression framework. Among them, the EA-rich spacer peptide (such as EAEAYVEFK, SEQ ID NO: 9) i...

Embodiment 2

[0082] Plasmid transformation and screening of MIP expression strains

[0083] 3ug of pPIC9K / B linearized with Bgl II 27 K-DtrI plasmid electrotransformed Pichia pastoris GS115 (his4) (purchased from NRRL, deposit number NRRL Y-15851, US6,730,499), 0.4cm electric shock cup, 2.4KV, 5.3ms, two consecutive electric shocks, transformed yeast cells Painted MD board. Plasmid pPIC9K / B 27 After K-DtrI is linearized with Bgl II, after entering yeast cells, part of it will be re-circularized and integrated into the chromosome through single-point insertion to obtain Mut+ phenotype transformants, and the other part of the linear plasmid will be integrated into the chromosome through substitution to obtain Muts expression. Type transformants, during which multi-copy insertion integration will spontaneously form. Pick 1,500 single clones from the MD plate, culture them in 2ml of YPD medium at 30°C for 24 hours, take 2μL and spot them on YPD plates containing 0.5, 1, 2, and 4 mg / ml of G4...

Embodiment 3

[0086] 2L scale fermentation

[0087] High-density fermentation is an effective means to obtain a large amount of heterologous protein from methanol yeast. Methanol yeast can grow in a simple inorganic salt medium. Harmful products such as alcohol and acetic acid are rarely produced during the fermentation process, so it is suitable for large-scale high-density fermentation . The pH value of the fermentation broth has a significant impact on the growth state of the cells and the stability of the secreted protein. The pH range of the fermentation was preliminarily optimized by shaking table experiments to be 4.5-6.5, and the optimal pH value was 5 (Figure 3).

[0088] Each liter of basic inorganic salt medium (basal salt medium, BSM) contains: 50ml glycerol, 26.7mlH 3 PO 4 , 0.93g CaSO 4 2H 2 O, 18.2 g K 2 SO 4 , 14.9 g MgSO 4 ·7H 2 O), and 4.13 g KOH, autoclaved with NH 4 OH to adjust the pH value.

[0089] The formula of trace element solution (PTM1) is 1L containin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a novel process for genetic engineering preparation of insulin and insulin analogs, which comprises enzyme cutting insulin precursor with parenzyme, then isolating insulin, wherein the insulin precursor comprises the following elements from amino end to carboxyl end, (1) spacing peptide element with formula (Xaa)mZ, (2) insulin B chain element, (3) joint peptide element with formula (Xaa)nZ, and (4) insulin A chain element.

Description

technical field [0001] The present invention relates to the field of bioengineering. More specifically, the present invention relates to the genetic engineering preparation method of novel insulin and insulin analogues. Background technique [0002] Insulin has been used to treat diabetes since the 1920s, and it is still an irreplaceable diabetes drug. There are now more than 120 million people with diabetes in the world, and it is expected to be 300 million by 2025, of which 10% are type I diabetes. Each patient with type I diabetes needs 1.4-2.1 mg of insulin per day, and patients with type II diabetes also have a considerable demand for insulin. Developed countries consume 4,600 kilograms of insulin per year. In addition, some new drug delivery methods can improve the patient's medication compliance, but the bioavailability is low, and more insulin is required compared with injection. Therefore, while preventing and controlling diabetes, it is imperative to develop a m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/435
Inventor 张友尚费俭丁金国崔大敷蔡国强石嘉豪
Owner 费俭
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products